1. P422 Immunogenicity of a proposed adalimumab biosimilar, FKB327, and the reference product in patients with rheumatoid arthritis. (25th January 2019) Authors: Alten, R; Markland, C; Kawakami, K; Boyce, M; Casty, F; Muniz, R; Genovese, M C Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S320 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗